No abstract
Curr Diab Rep. 2026 Apr 10;26(1):9. doi: 10.1007/s11892-026-01622-9.
NO ABSTRACT
PMID:41961366 | DOI:10.1007/s11892-026-01622-9
Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes
Scritto il 10/04/2026
da Larissa Araújo de Lucena